Avante At Inverness Inc | |
304 S Citrus Ave, Inverness, Florida 34452 | |
(352) 726-3141 | |
Name | Avante At Inverness Inc |
---|---|
Location | 304 S Citrus Ave, Inverness, Florida |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 104 |
Occupancy Rate | 91.25% |
Medicare ID (CCN) | 105308 |
Legal Business Name | Avante At Inverness, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1750464830 |
Organization Name | AVANTE AT INVERNESS, INC. |
Address | 304 S Citrus Ave, Inverness, FL 34452 |
Phone Number | 954-987-7180 |
News Archive
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
AEterna Zentaris Inc. has reported it has reached its goal of recruiting 500 patients for the safety study of the Phase 3 program in benign prostatic hyperplasia (BPH) with its flagship product candidate, cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist.
A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting antibiotic-resistant infections.
While natural disasters and economic recessions traditionally unleash an uptick in child abuse, a new study suggests that cases may have declined in the first months of the pandemic, compared with the same timeframe in previous years.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
AEterna Zentaris Inc. has reported it has reached its goal of recruiting 500 patients for the safety study of the Phase 3 program in benign prostatic hyperplasia (BPH) with its flagship product candidate, cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist.
A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting antibiotic-resistant infections.
While natural disasters and economic recessions traditionally unleash an uptick in child abuse, a new study suggests that cases may have declined in the first months of the pandemic, compared with the same timeframe in previous years.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $3250 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.74 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.89 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 61.16 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.46 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.29 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.95 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.67 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.6 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.97 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 19.61 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.58 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.97 | 95.98 |
Percentage of short-stay residents who made improvements in function | 82.72 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.05 | 82.93 |
News Archive
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
AEterna Zentaris Inc. has reported it has reached its goal of recruiting 500 patients for the safety study of the Phase 3 program in benign prostatic hyperplasia (BPH) with its flagship product candidate, cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist.
A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting antibiotic-resistant infections.
While natural disasters and economic recessions traditionally unleash an uptick in child abuse, a new study suggests that cases may have declined in the first months of the pandemic, compared with the same timeframe in previous years.
› Verified 6 days ago
Arbor Trail Rehab And Skilled Nursing Center Location: 611 Turner Camp Rd, Inverness, Florida 34453 Phone: (352) 637-1130 | |
Citrus Health And Rehabilitation Center Location: 701 Medical Court East, Inverness, Florida 34452 Phone: (352) 860-0200 |